Cydan's Series B Round

Cydan raised a round of funding on October 11, 2017.

Cydan is an orphan drug accelerator that identifies and de-risks assets with therapeutic and commercial potential. The accelerator's model evaluates programs for treating rare diseases with high unmet…

Articles about Cydan's Series B Round: